Sept 28 (Reuters) – Merck & Co Inc: * SAYS MERCK ENTERS EXCLUSIVE GLOBAL LICENSE DEAL WITH SCIBRUNCH THERAPEUTICS FOR INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR SPR2015 Source text Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By خدمة تقصي الحقيقة (The article has been published through a syndicated feed. Except for…
By Iain Withers, Liang-sa Loh and Inti Landauro LONDON/TAIPEI/PARIS, Nov 13 (Reuters) - Old-school technology…
(Specifies wording in paragraph 2 to clarify Asmodee publishes and distributes board games.) By Vera…
* Budget committee backs €561 billion spending plan after weeks of coalition talks * Total…
By Iain Withers, Liang-sa Loh and Inti Landauro LONDON/TAIPEI/PARIS, Nov 13 (Reuters) - Old-school technology…
Nov 13 (Reuters) - A more than 12-hour outage of Microsoft Outlook and Teams crippled…